跳至主要内容
临床试验/NCT07197541
NCT07197541进行中(未招募)4 期

A Self-controlled Study of Bleomycin and Pingyangmycin Injection in the Treatment of Plantar Warts

Second Affiliated Hospital, School of Medicine, Zhejiang University1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2025年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
进行中(未招募)
发起方
入组人数
200
试验地点
1
主要终点
Skin lesions completely cleared

研究概览

简要总结

All patients were treated as self-control. Half of the warts received bleomycin injection and the other half received pingyangmycin injection for 24 weeks. During the treatment period, before each injection, photos of the skin lesions must be taken, the diameter of the skin lesions must be measured, the DLQI(Dermatology Life Quality Index) and NRS scores(NRS scores) must be filled in, and adverse events must be recorded. Before the first treatment, HPV(Human Papilloma virus) virus typing is performed on the warts.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged over 18 years old;
  • Clinical diagnosis of plantar warts;
  • The diameter of a single wart is ≥1cm, and the number is ≥2;
  • There is a history of other treatments for plantar warts within 4 weeks, including drugs and physical therapy;
  • Have a basic understanding of the purpose, effects and possible adverse reactions of the trial, and sign an informed consent form in accordance with the spirit of the Declaration of Helsinki.

排除标准

  • There are other local infections in the treatment area and injection is not suitable;
  • Patients allergic to lidocaine, bleomycin, and pingyangmycin;
  • Patients with other serious skin diseases, tumors or other systemic diseases;
  • Patients with infections such as tuberculosis, HIV, hepatitis B, hepatitis C;
  • Patients with a history of other treatments for plantar warts in the previous 4 weeks, including drugs and physical therapy;
  • Patients who have participated in other clinical trials in the past 3 months;
  • Pregnant women, lactating women, or patients who plan to become pregnant during the trial;
  • Those who have any history of major surgery in the previous 8 weeks or who may have surgery planned during treatment;
  • Patients with a history of mental illness.

研究组 & 干预措施

Pingyangmycin group

Experimental

干预措施: Pingyangmycin Injection (Drug)

Bleomycin group

Experimental

干预措施: Bleomycin injection (Drug)

Bleomycin Combined with Local Hyperthermia

Experimental

干预措施: Bleomycin injection (Drug)

结局指标

主要结局

Skin lesions completely cleared

时间窗: Week 24

The patient's plantar wart lesions were completely cleared

Skin lesions completely cleared

时间窗: 2026.11.1

The patient's plantar wart lesions were completely cleared

次要结局

  • Follow up to 36 weeks with no recurrence(Week 52)
  • Follow up to 36 weeks with no recurrence(2026.11.1)

研究者

发起方
Second Affiliated Hospital, School of Medicine, Zhejiang University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验